The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals and Sanofi's Dupixent (dupilumab) as an add-on maintenance treatment for adolescent patients aged...
The United States Food and Drug Administration (U.S. FDA) has approved Roche's OCREVUS ZUNOVO (ocrelizumab & hyaluronidase-ocsq) for the treatment of relapsing multiple sclerosis...
Pioneer Group, a specialist in life science infrastructure and venture building, has teamed up with global healthcare company Novo Nordisk to launch a Golden...